Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales & Procedure Volume, ASP by Product Type, Application & End-users The global endoscopy devices market will witness a robust CAGR of 7.1%, valued at $30.3 billion in 2021, expected to appreciate and reach $56.2 billion by 2030, confirms Strategic Market Research. North America had the greatest revenue share of 42.3 % in the market in 2021. There is a diverse use of endoscopic instruments in the medical field, and it varies concerning the procedures the professionals follow for instance, colonoscopy surgeries, arthroscopy surgeries, laparoscopic procedures, and various others. These devices permit the doctors to take samples and execute the course of action. Each device has its purpose and is used in the niche field. Some of the devices are cleaning brushes, Tube sets, Tissue scissors and cutters, Biopsy Forceps, tissue staplers, and ligation devices. An endoscopy is a technique that uses an endoscope to examine internal body parts like the gastrointestinal tract, respiratory tract, urinary tract, reproductive tract, closed body cavities, digestive tract, etc. Endoscopes are made up of a long, thin tube inserted straight into the body to see an inner organ or tissue in great detail. An endoscope is placed through the mouth into the oesophagus while performing an upper endoscopy that allows the doctor to examine the stomach, oesophagus, and upper portion of the small intestine. Endoscopes can also be introduced through the rectum into the large intestine (colon) to check this part of the intestine. This operation is called sigmoidoscopy or colonoscopy, based on how far up the colon is inspected. Endoscopic retrograde cholangiopancreatography, or ERCP, is an endoscopy that allows images of the gallbladder, pancreas, and adjacent structures. Biopsies and stent implantation are also performed with ERCP. According to the American Cancer Society, CRC (Colorectal Cancer ) affects about 4.4 % of males (1 in 23) and 4.1 % of women (1 in 25) in their lifetime. Men are 30 % more likely than women to get CRC, with the discrepancy being greater for rectal cancer (60 % higher) than colon cancer (20 % higher). A surge in the number of chronic diseases and FGIDs, a rise in the number of the elderly population, higher adaption of technology, and improved R&D are some of the most promising drivers of the industry. Market Drivers - Growing Demand For Endoscopic Equipment, A Rising Number Of FGID, And A Rise in The Population of Older Adults The growing need for endoscopy equipment in diagnostic and therapeutic procedures drives the endoscopy device market. Using such devices in diagnosing and treating various illnesses is required since it allows for little intervention and a faster recovery period. As minimally invasive surgeries have increased, numerous endoscopes in surgical procedures such as arthroscopy, laparoscopy, and other operations use minimally invasive devices (endoscopic ultrasound to perform ultrasound-guided tissue acquisition). More than 40% of the people globally have functional gastrointestinal disorders, impacting the quality of life and healthcare utilization in a large-scale multinational investigation. Moreover, the industry is predicted to rise as the elderly population grows. According to the United States Census Bureau, the elderly population in the United States is predicted to reach 77 million by 2034. From 2000 to 2020, Harvard Medical School looked at annual medical data on more than 23 million adults aged 67 and up. Crohn's disease cases climbed by 3.4 % per year, whereas ulcerative colitis cases increased by 2.8%. Market Restraints - High Cost of Endoscopy Process, Device Callback, Lack of Skilled Professionals, And Limited Reimbursement. An increasing product recall rate due to a faulty system, higher cost of endoscopy processes like endoscopic retrograde cholangiopancreatography, lack of skilled professionals in devices like endoscopy VR simulators, and limited reimbursement are the factors affecting the growth rate of the industry. Opportunities - Technological Advancement and Improved R&D, And the Growing Popularity of Hyperspectral Imaging For companies in the global industry, R&D of new endoscopic technologies (like augmented reality) is likely to offer attractive development prospects. For example, Xenocor, Inc. was awarded a patent in June 2020 for the Xenoscope Single-use Laparoscopic System, which offers essential protection for materials used in the disposable scope that prevents fogging and increases the clarity of the system's producing pictures. Hyperspectral imaging's growing popularity will likely provide attractive growth prospects for participants available globally in the industry. In vivo cancer detection has been achieved using hyperspectral endoscopy devices combined with rigid endoscopy. Market Analysis Of Different Segments Covered in the Report Based on Product Endoscopes Rigid Endoscopy Devices Arthroscopes Laparoscopes Urology endoscopes Neuroendoscopes Gynecology endoscopes Cystoscopes Other endoscopy devices Flexible Endoscopy Devices Laryngoscopes Upper GI endoscopes Bronchoscopes Rhinoscopes Colonoscopes Nasopharyngoscopes Duodenoscopes Pharyngoscopes Sigmoidoscopes Other Endoscopy Devices Robot-Assisted Endoscopy Devices Capsule Endoscopy Devices Disposable Endoscopy Devices Endoscopy Visualization Systems High-Definition Visualization Systems 3D systems 2D systems Standard Definition Visualization Systems 3D system 2D system Endoscopy Visualization Components Light Sources Insufflators Camera Heads Video Processors Suction Pumps Endoscopy High-definition monitor Operative Devices Snares Wound Retractors Suction and Irrigation Systems Access Devices Hand Instruments Energy Systems Based on Application GI endoscopy Otoscopy Obstetrics or gynecology endoscopy Laproscopy Larngoscopy Urology endoscopy or cystoscopy Mediastinoscopy Bronchoscopy Arthroscopy Other applications Based on End-user Ambulatory surgery centers Hospitals Other end-uses Regional Coverage Analysis North America Canada USA Europe UK. Spain Denmark France Germany Russia Switzerland Italy Asia Pacific India China Australia Japan New Zealand Philippines Indonesia Vietnam Malaysia Thailand Latin America Argentina Brazil Mexico Middle East Africa Qatar Saudi Arabia Israel Kuwait UAE South Africa Worldwide biopsy forceps valuation is approximately USD 260.8 million in 2022. Key companies in Biopsy are Scanlan international, Medi-globe GmbH and Omnimed ltd., Cardinal Health, Steris Corporation, Olympus Corporation, and Boston Scientific Corporation. Biopsy forceps are used in laparoscopy, hysterectomy, and hysteroscopy. North America is the leader in biopsy forceps due to the jump in chronic diseases, which paves the way for surgical procedures. Cancer and Gastrointestinal infections are fatal diseases steering the demand for biopsy sampling. The Report of WHO states that 10 million people died from cancer in 2020. International Agency for Research on Cancer has forecasted that by 2040, 27.5 million new cases will be on the cards, and 16.3 million deaths will happen due to cancer. Europe comes 2nd in biopsy as technological advancement plays a big part in improving the product and its efficiency. Ligation devices are used in gynecological and urological surgeries and laparoscopic procedures. It is forecasted to reach a global market of US$ 1.5 billion by the end of 2028. As per the American Congress of Obstetricians and Gynecologists, percentage of minimally invasive hysterectomy procedures in the USA has increased from 14% in 2004 to 53% in 2013. Product Analysis & Insights The Endoscopy visualization systems segment held the highest revenue due to their increasing acceptance during endoscopy processes and increased application for the diagnosis and visualization of complex diseases such as GI disorders, cancer, lung disorders, and urinary disorders with a share of 36.5 % in 2021. According to GI Alliance, Twenty million Americans suffer from chronic digestive illnesses, which account for one-quarter of all surgical procedures. Colorectal cancer is the 2nd largest cause of cancer death in men and women in the United States, accounting for about 51,000 fatalities annually. Furthermore, the endoscopes sector registered a CAGR of 9.2 % throughout the projection period for endoscopic equipment. This rapid expansion is attributable to an increase in the total number of endoscopic operations performed and the widespread use of endoscopes to conduct biopsies and surgeries for improved diagnosis and cure. Flexible endoscopes led the endoscopes market in 2021, accounting for a large revenue share because medical professionals prefer them as it imbibes the benefits such as higher efficiency, safety, and improved ergonomics compared to rigid endoscopes. According to the American Society for Metabolic and Bariatric Surgery (ASMBS) findings, 256,000 bariatric surgeries were carried out in the United States in 2019. Endoscopy has become an important tool for evaluating and managing complications and main bariatric procedures, boosting demand for flexible endoscopes. Application Analysis & Insights The endoscopy devices market was led by the Gastrointestinal (GI) endoscopy sector, and hence the gastrointestinal devices market holds 53.2 % of total revenue. The surging elderly population and the continuous rise in the burden of functional gastrointestinal illnesses are solely responsible for this significant percentage of the market. Moving forward, the urology endoscopy segment is expected to develop quickly throughout the forecasted years due to the rising frequency of chronic urological disorders such as tumors and cancer and the increasing number of cystoscopy surgeries. Colorectal cancer, in men and women, was the third most frequent cancer in 2020, according to the WCRFI, with more than 1.9 million new cases reported. According to the American Cancer Society, 1,880,725 people were detected with colorectal cancer in 2020. Colon cancer accounts for 1,148,515 cases, whereas rectal cancer accounts for 732,210 cases. In 2020, colorectal cancer, the second leading cause of cancer-related death worldwide, killed 915,880 people. Because cystoscopy is one of the most common ways to diagnose bladder cancer, it is expected to drive sector development in the coming years. Endoscopy devices are used for symptoms like stomach pain, ulcer, gastritis, digestive tract bleeding, chronic constipation or diarrhea, and polyps (growth in the colon). Worldwide, it is estimated that 5-10% of the population has IBS. Most of the people with IBS come under the age of 50. Worldwide, 20% to 40% population visit gastroenterologists due to IBS symptoms. IBS affects between 25 to 45 Mn people in the United States. Colorectal cancer is the 3rd most diagnosed cancer. Around 1.4 million new cases and nearly 700,000 deaths were recorded in 2012 due to colorectal cancer (CRC). The Global burden of CRC is likely to increase by 60% and will reach to more than 2.2 million new cases and 1.1million deaths by 2030. End-User Analysis & Insights The hospital sector led the market for endoscopic equipment, accounting for 48.1 % of total sales. Hospitals are widely regarded as the main health care providers, and the patient population's growing preference for hospitals to diagnose and treat chronic illnesses is propelling sector expansion. Around 85 % of individuals, according to the National Council on Aging, have at least one chronic illness. Chronic illnesses account for $3.8 trillion in annual healthcare costs. Chronic pain and diabetes are the costliest chronic conditions, with yearly costs of $635 billion and $327 billion. Furthermore, the ambulatory surgery centers/clinics sector is expected to grow fastest throughout the projection years. Some of the primary elements projected to fuel the segment's growth include the growing demand for minimally invasive surgeries to cut total costs and the number of hospitalization days. Region Analysis & Insights North America had the greatest revenue of 42.3 % in the market in 2021, attributable to the rising prevalence of chronic illnesses such as diabetes, cancer, cardiovascular disease, and functional gastrointestinal problems. According to the American Heart Association, approximately 605,000 new heart attacks and 200,000 repetitive heart attacks occur in the United States. A stroke occurs every 40 seconds, resulting in one out of 19 fatalities. The rise in the number of endoscopic operations done in the United States is projected to propel the industry to grow at a rate of roughly 7.2 % during the projected period. Furthermore, due to the huge population and rising count of patients with functional gastrointestinal problems in the Asia Pacific, the industry is predicted to develop quickly throughout the forecast years. The market in India is projected to register a CAGR of 6.91% during the forecast period. According to one research article, In 2035, a 2.5-fold increase in prevalence was predicted for Iran, with 69 thousand cases, a 2.3-fold increase for North Africa and the Middle East with 220 thousand cases, a quadrupling of prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia with 4.5 million cases, and a 1.6-fold increase for the high-income Asia Pacific and Southeast Asia regions with 183 and 199 thousand cases, respectively, compared to 2020. Endoscopy Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in the year 2021 USD 30.3 billion The revenue forecast in the year 2030 USD 56.2 billion Overall Growth rate CAGR of 7.1 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Application, By End Users, By Region. By Product Endoscopes, Endoscopy Visualization Systems By Application Gastrointestinal (GI) endoscopy, Arthroscopy, Laparoscopy, Obstetrics or Gynecology Endoscopy, Urology endoscopy or cystoscopy, Laryngoscopy, Bronchoscopy, Mediastinoscopy, Otoscopy, Other applications. By End-User Ambulatory surgical centers, Hospitals, and Other end-uses By Region North America, Asia Pacific, Europe, Latin America, The Middle East, and Africa Country Scope India, France, United States, Mexico, Canada, Germany, UK, France, China, Italy, Japan, etc Company Usability Profiles J&J Services Inc., Interscope Inc., Micro-Tech Endoscopy, Stryker, OLYMPUS, KARL STORZ Gmbh & Co. KG, FUJIFILM, Shaili Endoscopy, Cantel Medical. Global Endoscopy Devices Market Competitive Landscape Analysis The competitive landscape scenario presents a detailed analysis of the major industry players operating in the global and regional markets. Product innovation and continued R&D operations, SWOT analysis and Porter’s five forces to create sophisticated technologies have assisted the overall market growth. In the target market, there are many key companies, and some of the industries are: Cantel Medical Integrate Endoscopy FujiFilm J&J Sevices Inc. Interscope Inc. Cogentix Medical Micro-Tech Endoscopy Richard Wolf Pentax Medical KARL STORZ Gmbh & Co. KG Shaili Endoscopy Olympus Stryker Recent Developments: On April 2022, The US FDA gave SonoScape's HD-550 endoscopy system 510(k) clearance for gastrointestinal diagnostics. The video endoscopy system includes a high-quality 4-LED light source with 1080P and multi-mode and multi-spectrum capabilities. It enables the capturing and recording of photographs and videos and access to patient data to create and edit reports without the need for additional software. The HD-550 consists of chromoendoscopy versatile, intelligent staining technology and spectrum-focused imaging (SFI) light modes that improve mucosal and vascular colour contrast and complement the white-light mode. On March 2022, at ECR 2022 Overture, an online event held on March 2-6, FUJIFILM Healthcare Europe demonstrated ECHELONTM Smart Plus with 'REALISE Plus,' a superconductive 1.5T MRI system with a completely new version of the SynergyDrive Automation Suite. Thanks to an excellent improvement of the SynergyDrive Automation Suite, ECHELON Smart Plus with 'REALISE Plus' goes to the next level. SynergyDrive was created to eliminate bottlenecks in the MRI workflow by scanning and streamlining essential operations, resulting in speedy, reliable findings and high-quality images. On August 2021, the ELUXEO 7000X endoscopic Imaging System was commercially released by Fujifilm Holdings Corporation. This innovative imaging technology allows for real-time observation of hemoglobin oxygen saturation (StO2) levels in tissue during laparoscopic and endoluminal imaging procedures. On January 2021, Olympus Corporation acquired Quest Innovations. Due to the purchase, Olympus expanded its surgical endoscopic capabilities and added Quest's advanced FIS capabilities to its entire medical imaging platform. On April 2020, EVIS X1, Olympus Corporation's most sophisticated endoscopic system to date, was released. By offering every endoscopist unique and established technologies, the new system aims to enhance outcomes from stomach disorders, colon, oesophagus, and bronchial ailments. Olympus' leadership in endoscopy and continuous medical emphasis is further strengthened with the debut of EVIS X1. Various Types of Equipment that the Key Industry Players are Manufacturing: Name of the Device Feature Key Player GF-UE160-AL5 The GF-UE160-AL5 improves resolution and penetration depth, making it simpler to establish blood flow conditions in the pancreatobiliary area. OLYMPUS 1588 AIM With nine specialized surgical camera specialty settings and five sophisticated imaging modalities: ENV, IRIS, Clarity, DRE, and DESAT, this high-definition camera system can assist discern important anatomy. Stryker PlasmaTYPHOON By completely drying the scopes, PlasmaTYPHOON reduces the danger of infection. Inadequate drying might result in microbial contamination and infectious material transfer. PENTAX Frequently Asked Question About This Report What is the endoscopy devices market growth? Endoscopy market share is projected to grow at a CAGR of 7.1 %. Which are the top industry players in the global market? Top industry players are: J&J Services Inc., Shaili Endoscopy, Interscope Inc., Cantel Medical, Micro-Tech Endoscopy, Stryker, OLYMPUS, KARL STORZ Gmbh & Co. KG etc.; out of which Olympus endoscope market share was 70 %. What devices use endoscopy? An endoscopy is a procedure in which a doctor inserts an instrument called an endoscope into a patients body. Most endoscopes are slender tubes with a bright light and a small camera at the tip. Is an endoscopy a surgical procedure? Endoscopy is a medical treatment that allows a doctor to look into a patients body for foreign body management without significant surgery. How big is an endoscopy scope? Standard upper endoscopes have an exterior diameter of 8.0 to 9.8 mm and a 2.4 to 2.8 mm channel diameter. Therapeutic channel scopes have an outside diameter of 11.3 to 13.2 mm, a 3.2 to 3.7 mm instrument channel, and twin channels up to 3.8 mm in diameter in bigger scopes. What is called an endoscope? Endoscopes are made up of a long, thin tube inserted straight into the body to see an inner organ or tissue in great detail. What is there in the endoscopy equipment list? The types of equipment are: polypectomy devices, capsule enteroscopy devices, endoscopy VR simulators, video capsule endoscopy devices, Roth net retrieval devices, urology devices, colonoscopy devices, sigmoidoscopy devices, bleed management and irrigation devices (GI endoscopy devices), otoscopy devices, laparoscopy devices, enteroscopy devices like video capsule enteroscopy devices, biopsy forceps, disposable endoscopy devices, trocar sleeves, tissue scissors and cutters, burs, cleaning brushes, tube sets, tissue staplers, ligation devices, suturing systems, etc. What is the market value of the Endoscopy devices market in 2030? Endoscopy devices market share will be $ 56.2 billion by 2030. How much is the total market value of the Endoscopy Devices market report? Endoscopy devices market size was $ 30.3 billion in 2021 and is estimated to reach $56.2 Billion by 2030, representing a CAGR of 7.1%. How big is the endoscopy devices market? In 2020, the Global Endoscopy Devices Market share was USD 30.3 billion. It is predicted to reach USD 56.2 billion by 2030, with a CAGR of 7.1% throughout the forecasted period. Sources https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html https://gialliance.com/gastroenterology-blog/digestive-disease-continues-to-rise-among-americans https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers https://www.ncoa.org/article/get-the-facts-on-chronic-disease-self-management 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Endoscopy Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Endoscopy Devices Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Endoscopes 7.3.1. Endoscopes, 2021 - 2030 (USD Million) 7.3.1.1 Rigid Endoscopy Devices, 2021 - 2030 (USD Million) 7.3.1.1.1 Laparoscopes, 2021 - 2030 (USD Million) 7.3.1.1.2 Arthroscopes, 2021 - 2030 (USD Million) 7.3.1.1.3 Urology endoscopes, 2021 - 2030 (USD Million) 7.3.1.1.4 Cystoscopes, 2021 - 2030 (USD Million) 7.3.1.1.5 Gynaecology endoscopes, 2021 - 2030 (USD Million) 7.3.1.1.6 Neuroendoscopes, 2021 - 2030 (USD Million) 7.3.1.1.7 Other rigid endoscopes, 2021 - 2030 (USD Million) 7.3.2.1 Flexible Endoscopy Devices, 2021 - 2030 (USD Million) 7.3.2.1.1 Upper gastrointestinal endoscopes, 2021 - 2030 (USD Million) 7.3.2.1.2 Colonoscopes, 2021 - 2030 (USD Million) 7.3.2.1.3 Bronchoscopes, 2021 - 2030 (USD Million) 7.3.2.1.4 Sigmoidoscopes, 2021 - 2030 (USD Million) 7.3.2.1.5 Laryngoscopes, 2021 - 2030 (USD Million) 7.3.2.1.6 Pharyngoscopes, 2021 - 2030 (USD Million) 7.3.2.1.7 Duodenoscopes, 2021 - 2030 (USD Million) 7.3.2.1.8 Nasopharyngoscopes, 2021 - 2030 (USD Million) 7.3.2.1.9 Rhinoscopes, 2021 - 2030 (USD Million) 7.3.2.1.10 Other flexible Endoscopy Devices, 2021 - 2030 (USD Million) 7.3.3.1 Capsule Endoscopy Devices, 2021 - 2030 (USD Million) 7.3.4.1 Disposable Endoscopy Devices, 2021 - 2030 (USD Million) 7.3.5.1 Robot-Assisted Endoscopy Devices, 2021 - 2030 (USD Million) 7.4. Endoscopy Visualization Systems 7.4.1. Endoscopy Visualization Systems Market, 2021 - 2030 (USD Million) 7.4.1.1 Standard Definition (SD) Visualization Systems, 2021 - 2030 (USD Million) 7.4.1.1.1 2D systems, 2021 - 2030 (USD Million) 7.4.1.1.2 3D systems, 2021 - 2030 (USD Million) 7.4.1.2 High Definition (HD) Visualization Systems, 2021 - 2030 (USD Million) 7.4.1.2.1 2D systems, 2021 - 2030 (USD Million) 7.4.1.2.2 3D systems, 2021 - 2030 (USD Million) 7.4.1.3 Endoscopy Visualization Component, 2021 - 2030 (USD Million) 7.4.1.3.1 Camera Heads, 2021 - 2030 (USD Million) 7.4.1.3.2 Insufflators, 2021 - 2030 (USD Million) 7.4.1.3.3 Light Sources, 2021 - 2030 (USD Million) 7.4.1.3.4 High-Definition Monitors, 2021 - 2030 (USD Million) 7.4.1.3.5 Suction Pumps, 2021 - 2030 (USD Million) 7.4.1.3.6 Video Processors, 2021 - 2030 (USD Million) 7.4.1.4 Operative Devices, 2021 - 2030 (USD Million) 7.4.1.4.1 Energy Systems, 2021 - 2030 (USD Million) 7.4.1.4.2 Access Devices, 2021 - 2030 (USD Million) 7.4.1.4.3 Suction & Irrigation Systems, 2021 - 2030 (USD Million) 7.4.1.4.4 Hand Instruments, 2021 - 2030 (USD Million) 7.4.1.4.5 Wound Retractors, 2021 - 2030 (USD Million) 7.4.1.4.6 Snares, 2021 - 2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals Market, 2021 - 2030 (USD Million) 8.4. Ambulatory surgery centres 8.4.1. Ambulatory surgery centres Market, 2021 - 2030 (USD Million) 8.5. Other end-uses 8.5.1. Other end-uses Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Gastrointestinal (GI) endoscopy 9.3.1. Gastrointestinal (GI) endoscopy Market, 2021 - 2030 (USD Million) 9.4. Laparoscopy 9.4.1. Laparoscopy Market, 2021 - 2030 (USD Million) 9.5. Obstetrics/gynecology endoscopy 9.5.1. Obstetrics/gynecology endoscopy Market, 2021 - 2030 (USD Million) 9.6. Arthroscopy 9.6.1. Arthroscopy Market, 2021 - 2030 (USD Million) 9.7. Urology endoscopy (cystoscopy) 9.7.1. Urology endoscopy (cystoscopy) Market, 2021 - 2030 (USD Million) 9.8. Bronchoscopy 9.8.1. Bronchoscopy Market, 2021 - 2030 (USD Million) 9.9. Mediastinoscopy 9.9.1. Mediastinoscopy Market, 2021 - 2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.2. North America Market, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Cogentix Medical. 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. Integrate Endoscopy 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. J&J Services Inc 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. Shaili Endoscopy 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. Interscope Inc 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Cantel Medical 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Micro-Tech Endoscopy 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Stryker 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. OLYMPUS 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. KARL STORZ Gmbh & Co. KG 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. FUJIFILM 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. PENTAX MEDICAL 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. RICHARD WOLF 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development List of Tables (70 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Rigid Endoscopy Devices, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Flexible Endoscopy Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Capsule Endoscopy Devices, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Disposable Endoscopy Devices, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Robot-Assisted Endoscopy Devices, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Endoscopy Visualization Systems, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Standard Definition (SD) Visualization Systems, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR High Definition (HD) Visualization Systems, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Endoscopy Visualization Component, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Operative Devices, BY REGION, 2021-2030 (USD Million) TABLE 13. Market, By End-User, 2021-2030 (USD Million) TABLE 14. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Ambulatory surgery centres, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Other end-uses, BY REGION, 2021-2030 (USD Million) TABLE 17. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 18. Market FOR Gastrointestinal (GI) endoscopy, BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Laparoscopy, BY REGION, 2021-2030 (USD Million) TABLE 20. Market FOR Obstetrics/gynecology endoscopy, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Arthroscopy, BY REGION, 2021-2030 (USD Million) TABLE 22. Market FOR Urology endoscopy (cystoscopy), BY REGION, 2021-2030 (USD Million) TABLE 23. Market FOR Bronchoscopy, BY REGION, 2021-2030 (USD Million) TABLE 24. Market FOR Mediastinoscopy, BY REGION, 2021-2030 (USD Million) TABLE 25. Market FOR Otoscopy, BY REGION, 2021-2030 (USD Million) TABLE 26. Market FOR Laryngoscopy, BY REGION, 2021-2030 (USD Million) TABLE 27. Market FOR Other applications, BY REGION, 2021-2030 (USD Million) TABLE 28. Market, BY REGION, 2021-2030 (USD Million) TABLE 29. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 31. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 32. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 33. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 34. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 35. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 36. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 37. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 38. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 39. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 40. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 41. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 42. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 43. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 44. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 45. Cogentix Medical.: COMPANY SNAPSHOT TABLE 46. Cogentix Medical.: OPERATING SEGMENTS TABLE 47. Integrate Endoscopy: COMPANY SNAPSHOT TABLE 48. Integrate Endoscopy: OPERATING SEGMENTS TABLE 49. J&J Services Inc: COMPANY SNAPSHOT TABLE 50. J&J Services Inc: OPERATING SEGMENTS TABLE 51. Shaili Endoscopy: COMPANY SNAPSHOT TABLE 52. Shaili Endoscopy: OPERATING SEGMENTS TABLE 53. Interscope Inc: COMPANY SNAPSHOT TABLE 54. Interscope Inc: OPERATING SEGMENTS TABLE 55. Cantel Medical: COMPANY SNAPSHOT TABLE 56. Cantel Medical: OPERATING SEGMENTS TABLE 57. Micro-Tech Endoscopy: COMPANY SNAPSHOT TABLE 58. Micro-Tech Endoscopy: OPERATING SEGMENTS TABLE 59. Stryker: COMPANY SNAPSHOT TABLE 60. Stryker: OPERATING SEGMENTS TABLE 61. OLYMPUS: COMPANY SNAPSHOT TABLE 62. OLYMPUS: OPERATING SEGMENTS TABLE 63. KARL STORZ Gmbh & Co. KG: COMPANY SNAPSHOT TABLE 64. KARL STORZ Gmbh & Co. KG: OPERATING SEGMENTS TABLE 65. FUJIFILM: COMPANY SNAPSHOT TABLE 66. FUJIFILM: OPERATING SEGMENTS TABLE 67. PENTAX MEDICAL: COMPANY SNAPSHOT TABLE 68. PENTAX MEDICAL: OPERATING SEGMENTS TABLE 69. RICHARD WOLF: COMPANY SNAPSHOT TABLE 70. RICHARD WOLF: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Endoscopy Devices Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 13 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Endoscopy Devices, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Endoscopy Devices, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Endoscopy Visualization Systems to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Gastrointestinal (GI) endoscopy to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview